SubHero Banner
Text

1st Quarter 2025

Key topics in this quarter’s edition include:

  • Amvuttra (vutrisiran) for cardiomyopathy of transthyretin-mediated amyloidosis
  • Sebetralstat for hereditary angioedema
  • Nipocalimab for generalized myasthenia gravis

Download PDF

Text